INTERNATIONAL PATENT: CALIWAY BIOPHARMACEUTICALS CO., LTD. FILES APPLICATION FOR "OXYRESVERATROL AND DERIVATIVES THEREOF FOR USE IN LIPOLYSIS"

GENEVA, Aug. 10 -- CALIWAY BIOPHARMACEUTICALS CO., LTD. (32F. -9, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei CityTaiwan 221) filed a patent application (PCT/CN2025/074998) for "OXYRESVERATROL AND DERIVATIVES THEREOF FOR USE IN LIPOLYSIS" on Jan 24, 2025. With publication no. WO/2025/162329, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LING, Yu-fang (32F. -9, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei CityTaiwan 221)

Abstract: A method of reducing fat or treating obesity in a subject compris...